Asker Healthcare Group Reports Q3 2026 Financial Results

Asker Healthcare Group reported third-quarter 2026 sales growth of 15% year over year, including 5% organic growth. Adjusted EBITA increased 24%, while its trailing 12-month EBITDA margin reached 10%. Gothenburg operations transition costs weighed on results, but management said acquisition momentum remained strong and the project pipeline robust.